HIV vaccines: The effect of the mode of action on the coexistence of HIV subtypes

Mathematical Population Studies

Volumn 8, Issue 2, 2000, Pages 205-229

  Porco, Travis C ^a   Blower, Sally M ^b  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Competitive exclusion; HIV vaccine; HIV 1 clade; HIV 1 subtype; Mathematical model

Indexed keywords

DISEASE CONTROL; HUMAN IMMUNODEFICIENCY VIRUS; MODEL; VACCINATION;

EID: 0034453624     PISSN: 08898480     EISSN: None     Source Type: Journal    
DOI: 10.1080/08898480009525481     Document Type: Article

References (39)

1. The population biology of the interaction between HIV-1 and HIV-2: Coexistence or competitive exclusion?
2. Dual infection with Human Immunodeficiency Virus type 1 of distinct envelope subtypes in humans
3. A perspective on AIDS vaccines
4. Health policy modeling: Epidemic control, HIV vaccines, and risky behavior
5. Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco
6. AIDS: Modeling epidemic control
7. Global Distribution of Human Immodeficiency Virus-1 Clades
8. Langerhans cell tropism of human immunodeficiency virus type 1 Subtype A through F isolates derived from different transmission groups
9. Biologically diverse molecular variants within a single HIV-1 isolate
10. State of the Science. HIV Vaccine development
11. o in epidemic theory
12. The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention
13. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: Implications for HIV vaccine trials
14. Assessing HIV vaccine effects
15. Assessing effects of vaccines on contagiousness and risk factors for transmission
16. Increasing antigenic and genetic diversity of the V3 variable doman of the Human Immonudeficiency virus envelope protein in the course of the AIDS epidemic
17. HIV-1 subtypes and male-to-female transmission in Thailand
18. Vaccination against colonizing bacteria with multiple serotypes
19. Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines
20. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations
21. Two anti-generally distinct subtype of Human Immunodeficiency Virus Type 1: Viral genotype predicts neutralization serotype
22. Probability of female-to-male transmission of HIV-1 in Thailand
23. Why do HIV-1 subtypes segregate among persons with different risk behaviors in South Africa and Thailand?
24. Genetic variants of HIV in Thailand
25. HIV-1 genetic diversity
26. Imperfect vaccines and herd immunity to HIV
27. Modeling HIV vaccination
28. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T cell mixtures without displaying subtype-specific tropism
29. Designing HIV vaccination policies: Subtypes and cross-immunity
30. Molecular epidemiology of HIV in Madrid
31. HIV subtypes raise vaccine anxieties
32. Extensive variation of human immunodeficiency virus type-1 in vivo
33. Primary genetic characterization of HIV-1 isolates from WHO-sponsored vaccine evaluation by the RNase-A mismatch method
34. HIV-1 Langerhans' Cell tropism associated with heterosexual transmission of HIV
35. Natural protection against HIV-1 infection provided by HIV-2
36. HIV variability and perspectives for a vaccine
37. HIV type 1 variation in World Health Organization-Sponsored vaccine evaluation sites: Genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains